Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India | MicrobiomeTrials← Back to trialsNCT07209917
Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-03-01Est. Completion: 2029-05-01
Enrollment target: 348 participants Locations- KC General Hospital, Bangalore, Karnataka, India
- Swathi Mahila Sangha, Bangalore, Karnataka, India
- General Hospital Jayanagar (GHJ), Bengaluru, Karnataka, India
Other microbiome trials you might be interested in
EGFR OverexpressionLocally Advanced Solid TumorMetastatic Solid Tumor
This is a study for people with locally advanced or metastatic cancer for whom previous treatment was not successful. Ad…
Seoul, South KoreaEst. completion Jun 2027
Carcinoma, NeuroendocrineTumor, NeuroendocrineTumors, NeuroendocrineNeuroendocrine; CarcinomaSmall Cell; Receptors
Background:
High-grade neuroendocrine carcinomas (HGNEC) are cancers that develop in different parts of the body, inclu…
Bethesda, United StatesEst. completion Jul 30, 2027
CancerHead and Neck Squamous Cell CarcinomaHead and Neck Cancer
This research study will include patients with high risk locally advanced head and neck squamous cell carcinoma (LA-HNSC…
Toronto, CanadaEst. completion Mar 31, 2023